Latest

Latest Cambridge News

  • Latest Cambridge news stories and updates. What is happening today? All recent Cambridge news and developments. Live coverage and timeline of Cambridge. All you need to know about Cambridge.
Backing Waikato: Investing In Growth
Pennsylvania’s aging prisons weren’t built for today’s extreme weather – leaving women and seniors especially at risk of illness and death
AstraZeneca announces new strategic collaboration with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases
Efzimfotase alfa showed numerical improvement in Six-Minute Walk Test achieving mean difference of 17.05 metres vs placebo in treatment-naïve adolescents and adults…
Manchester and Cambridge bet on ‘co-opetition’ to take on the world
Appeal to locate woman missing from Cambridge Park
UNITAR co-hosts LifeSpan Summit Málaga 2026: shaping the future of the 100-year life
Alexion to showcase Phase III data in hypophosphatasia and hypoparathyroidism at ASBMR 2026 Annual Meeting
Physicists who uncovered the first particle accelerator were honored with a Nobel Prize 75 years ago – their work shaped physics, medicine…
AstraZeneca and Daiichi Sankyo announce clinical collaboration with Summit Therapeutics to evaluate Datroway in combination with ivonescimab across multiple tumour types
UPDATE: Serious Incident, Papatoetoe
Manchester City supporters have been gaslit. What happens now?
Serious Incident, Papatoetoe
Meta wants people to use ‘AI agents’ to do daily tasks for them. Here’s why that’s a problem
Council invests in community arts programs to strengthen local identity and activate public spaces
University of Melbourne strengthens global standing, continues to lead Australia in THE rankings
AstraZeneca announces strategic equity investment and clinical collaboration with Summit Therapeutics to advance leading ADC combination strategy in cancer
Perioperative Imfinzi plus neoadjuvant enfortumab vedotin granted Priority Review in the US for patients with muscle-invasive bladder cancer
Alexion advances pioneering leadership in gMG care with data at 2026 AANEM Annual Meeting and MGFA Scientific Session
Ashurst Perkins Coie advises Aboria Capital on circa £165m acquisition of five-asset UK student accommodation portfolio
Trixeo approved in the EU for the maintenance treatment of asthma
Serious crash involving cyclist at Cambridge in southern Tasmania
Klygefa (gefurulimab) recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis (gMG)
Efzimfotase alfa granted Priority Review in the US as treatment for patients with hypophosphatasia aged 2 years and older
Greyhound racing just turned 100, and says its dogs are fine. But are they?
Science Tokyo And MIT Launch New Collaboration
Royce Institute receives £95m funding to back the next generation of materials research
Tagrisso demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial
Justin Gooding’s Journey From Discovery To Impact
Update on SERENA-4 Phase III trial of Etcamah in combination with palbociclib in upfront 1st-line advanced ER-positive breast cancer
Black Holes Outgrow Their Galaxies
Curriculum innovation is key to delivering Australia’s university equity ambitions
Imfinzi plus Imdelltra demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stage small…
Tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations in OBERON and TITANIA Phase III trials
Etcamah in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
Science uncovers how the brain interprets artistic beauty – new research
Police Appeal To Locate Woman Missing From Werrington 3 September
A 13-metre rocket hit the Moon. Tasmanian researchers helped track it there
AstraZeneca completes global license agreement for oral EGFR inhibitor Zegfrovy for lung cancer
Tagrisso plus Orpathys demonstrated statistically significant and highly clinically meaningful improvement in progression-free survival in 1st-line MET-overexpressing EGFR-mutated lung cancer
Forgotten Women Philosophers Step Back Into Spotlight
Fatal traffic crash at Rockhampton City, QLD
New Associate High Court Judge appointed
Western Australians Recognised As John Monash Scholars
20 years. Millions of lives saved. One revolutionary vaccine
Tezspire demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
We can’t quit smartphones, but we can manage digital junk food better
The real reasons you procrastinate – and how to stop, according to science

© 2026 - The National Tribune Australia